MedPath

The Effectiveness of Flash Glucose Monitoring System on Glycemic Control in Patients With New-onset Type 2 Diabetes

Phase 4
Conditions
Diabetes Mellitus, Type 2
Flash Glucose Monitoring
Interventions
Device: Flash Glucose Monitoring System
Registration Number
NCT04535830
Lead Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Brief Summary

The purpose of this study is to determine if Flash glucose monitoring system improves glycemic control in adults with new-onset type 2 diabetes

Detailed Description

People with new-onset type 2 diabetes who achieve and sustain glycemic targets is important for reducing the risk of complications and all-cause mortality.Glucose monitoring is the key point of diabetes management.Continuous glucose monitoring(CGM)can identify day-to-day glucose profiles to guide management decisions.Flash glucose monitoring is a variant of CGM and is factory calibrated,requiring no finger pricks.The purpose of this study is to determine if Flash glucose monitoring improves glycemic control in adults with new-onset type 2 diabetes.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • peolpe with type 2 diabetes in accordance with the dignosed criteria of CDS2017
  • type 2 diabetes duration of <6months
  • with certain read-write ability
  • willing to use FSL or follow study protocol
Exclusion Criteria
  • acute complication of diabetes condition(DKA,HHH)
  • pregnancy,lactating or planning pregnancy
  • allergy to adhesive tape
  • skin with large area of rubefaction and wounds

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Flash glucose monitor system(FSL)Flash Glucose Monitoring SystemExcept at baseline and at the end of the experiment,participants at the FSL group will be asked to wear a flash glucose monitoring sensor for a period of 2 weeks and have a care visit every month.
Primary Outcome Measures
NameTimeMethod
the between-group difference in mean HbA1c3months

difference in mean HbA1c between FSL group and SMBG group

Secondary Outcome Measures
NameTimeMethod
the between-group difference in mean time in hypoglycemia3months

difference in mean time in hypoglycemia between FSL group and SMBG group

the between-group difference in mean time in other biochemical indexes,such as LDL-C,TC,TG and so on3months

difference in some biochemical indexes between FSL group and SMBG group

the between-group difference in mean time in target glucose range3months

difference in mean time in target glucose range between FSL group and SMBG group

Trial Locations

Locations (1)

Shanghai First People's Hospital

🇨🇳

Shanghai, Shanghai, China

Shanghai First People's Hospital
🇨🇳Shanghai, Shanghai, China
Yufan Wang, Doctor
Contact
18918236256
yyffwangdr@yahoo.com
Ying Huang, Doctor
Contact
17321027916
hy952@163.com
© Copyright 2025. All Rights Reserved by MedPath